Get the Stockscreener App
11.29
8.99%
-1.115
After Hours:
11.49
0.205
+1.82%
Briacell Therapeutics Corp stock is traded at $11.29, with a volume of 127.39K.
It is down -8.99% in the last 24 hours and up +41.06% over the past month.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
See More
Previous Close:
$12.40
Open:
$12.4
24h Volume:
127.39K
Relative Volume:
0.16
Market Cap:
$21.26M
Revenue:
-
Net Income/Loss:
$-16.60M
P/E Ratio:
-12.68
EPS:
-0.89
Net Cash Flow:
$-23.48M
1W Performance:
-14.64%
1M Performance:
+41.06%
6M Performance:
+159.43%
1Y Performance:
-23.75%
1-Day Range:
$11.19
$12.53
1-Week Range:
$11.19
$13.40
52-Week Range:
$0.61
$19.05
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Name
Briacell Therapeutics Corp
Sector
Industry
Phone
(604) 921-1810
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
11.29 | 21.76M | 0 | -16.60M | -23.48M | -0.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-22 | Initiated | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Stock (BCTX) Latest News
Learn to Evaluate (BCT) using the Charts (BCT:CA) - news.stocktradersdaily.com
Best data tools to analyze BriaCell Therapeutics Corp. Equity Warrant stockWall Street Watch & Free Community Supported Trade Ideas - newser.com
BriaCell Therapeutics Corp. stock chart pattern explainedEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Applying Wyckoff theory to BriaCell Therapeutics Corp. Equity Warrant stockJuly 2025 Market Mood & High Yield Equity Trading Tips - newser.com
What institutional flow reveals about BriaCell Therapeutics Corp. Equity WarrantPortfolio Gains Summary & Reliable Price Breakout Alerts - newser.com
Is BriaCell Therapeutics Corp. stock attractive for growth ETFs2025 Risk Factors & Free Long-Term Investment Growth Plans - newser.com
BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025 - Investing News Network
Long term hold vs stop loss in BriaCell Therapeutics Corp.2025 Volume Leaders & Fast Entry Momentum Alerts - newser.com
BriaCell (BCTX) to Present Key Phase 3 Study Data at ESMO Congre - GuruFocus
Will BriaCell Therapeutics Corp. Equity Warrant stock benefit from infrastructure spending2025 Biggest Moves & AI Powered Market Entry Strategies - newser.com
BriaCell Reports Positive Phase 3 Biomarker Data for Metastatic Breast Cancer Treatment - TipRanks
p=0.0002: BriaCell Phase 3 biomarker shows DTH response linked to longer PFS, ESMO Oct 20 - Stock Titan
BriaCell Therapeutics Corp Stock Analysis and ForecastBreakout Stock Watch & Superior Capital Appreciation - earlytimes.in
What data driven models say about BriaCell Therapeutics Corp.’s future2025 Investor Takeaways & Smart Money Movement Tracker - newser.com
Combining machine learning predictions for BriaCell Therapeutics Corp. Equity WarrantJuly 2025 Update & AI Forecast Swing Trade Picks - newser.com
BriaCell Therapeutics : Investor Presentation (20251010 Investor Presentation) - MarketScreener
BriaCell Therapeutics Corp. Equity Warrant stock prediction for this weekStock Surge & Safe Entry Momentum Tips - newser.com
Risk adjusted return profile for BriaCell Therapeutics Corp. Equity Warrant analyzedJuly 2025 Technicals & Daily Stock Momentum Reports - newser.com
Why retail investors favor BriaCell Therapeutics Corp. Equity Warrant stockWeekly Trend Summary & Fast Moving Trade Plans - newser.com
How strong is BriaCell Therapeutics Corp. Equity Warrant stock balance sheetJuly 2025 Fed Impact & AI Based Buy and Sell Signals - newser.com
What earnings margins imply for BriaCell Therapeutics Corp. (8BT0) stockRate Hike & Technical Confirmation Trade Alerts - newser.com
A activityJuly 2025 Movers & Weekly Chart Analysis and Guides - newser.com
When (BCT) Moves Investors should Listen (BCT:CA) - news.stocktradersdaily.com
Will breakout in BriaCell Therapeutics Corp. Equity Warrant lead to full recoveryJuly 2025 Fed Impact & Fast Gain Swing Trade Alerts - newser.com
Will BriaCell Therapeutics Corp. continue its uptrendIPO Watch & Risk Managed Investment Strategies - newser.com
Is BriaCell Therapeutics Corp. trending in predictive chart modelsFed Meeting & Daily Growth Stock Tips - newser.com
How to monitor BriaCell Therapeutics Corp. Equity Warrant with trend dashboardsEarnings Risk Summary & Real-Time Chart Breakout Alerts - newser.com
What candlestick patterns are forming on BriaCell Therapeutics Corp. Equity WarrantCPI Data & Daily Profit Maximizing Tips - newser.com
What analysts say about BriaCell Therapeutics Corp stockSupport Level Holds & Access Advanced Stock Screening Tools - earlytimes.in
Using Bollinger Bands to evaluate BriaCell Therapeutics Corp. Equity WarrantWeekly Trend Summary & Risk Managed Investment Strategies - newser.com
Is BriaCell Therapeutics Corp. meeting your algorithmic filter criteriaBuy Signal & Expert Curated Trade Ideas - newser.com
Published on: 2025-10-05 05:44:06 - newser.com
Using flow based indicators on BriaCell Therapeutics Corp. Equity WarrantQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com
(BCT) Advanced Trading Insights (BCT:CA) - news.stocktradersdaily.com
Published on: 2025-10-05 03:55:06 - newser.com
How hedge fund analytics apply to BriaCell Therapeutics Corp. stockEarnings Overview Summary & Weekly High Return Opportunities - newser.com
Risk vs reward if holding onto BriaCell Therapeutics Corp. Equity WarrantJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting - GlobeNewswire
Stocks in play: BriaCell Therapeutics Corp. - The Globe and Mail
BriaCell to Present Innovative Cancer Vaccine Data at SITC 2025 - TipRanks
Why BriaCell Therapeutics Corp. stock is a value investor pickQuarterly Profit Report & AI Enhanced Market Trend Forecasts - newser.com
SITC 40th Anniversary: Bria-OTS+ Preclinical Poster — BriaCell to Present Nov 7, 2025 - Stock Titan
Briacell Therapeutics Corp Stock (BCTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):